tiprankstipranks
Trending News
More News >
9 Meters Biopharma (NMTRQ)
OTHER OTC:NMTRQ
US Market

9 Meters Biopharma (NMTRQ) Income Statement

Compare
1,950 Followers

9 Meters Biopharma Income Statement

Last quarter (Q1 2023), 9 Meters Biopharma's total revenue was $―, a decrease of ― from the same quarter last year. In Q1, 9 Meters Biopharma's net income was $-13.87M. See 9 Meters Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ ―$ ―$ ―$ ―$ ―
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ 8.52K$ 7.57K$ 18.49K$ -21.61K$ -19.55K
EBITDA
$ -39.30M$ -36.72M$ -57.43M$ -24.21M$ -15.48M
Operating Income
$ -42.02M$ -36.76M$ -60.88M$ -25.58M$ -18.22M
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -43.77M$ -36.78M$ -61.50M$ -27.13M$ -24.16M
Per Share Metrics
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

9 Meters Biopharma Earnings and Revenue History